logo black and white
BROWSE
MORE
CONTACT
WHERE TO WATCH
Log InorSign Up
logo color

Drugmakers Secure $2.1 Billion Vaccine Deal With U.S.

View Transcript
July 31, 2020
Two drugmakers secured a $2.1 billion dollar deal with the U.S. government to produce millions of doses of an experimental coronavirus vaccine. Dr. Peter Pitts, President of the Center for Medicine in the Public Interest, joined Cheddar to discuss.
thumbnail
WATCH NEXT
Bruce Lee's Daughter Shannon Lee Brings His 'Warrior' Vision to Life

Related

Sep 23, 2020
6:53
FDA to Announce Tougher Standards for Coronavirus Vaccine
Cheddar's Hena Doba is joined by Prof. Peter Pitts, Founder of the Center for Medicine in the Public Interest and Former FDA Commissioner to talk the latest on the Coronavirus pandemic.
Sep 18, 2020
6:11
Eli Lilly Says New Antibody Treatment Reduces Rate of Hospitalizations for COVID-19
In addition to the search for a vaccine, drug companies are working to find effective treatments to reduce coronavirus symptoms and potentially prevent hospitalization. This week, pharmaceutical company Eli Lilly announced a breakthrough in their antibody research, as well as a potential treatment option with a drug commonly used to treat rheumatoid arthritis. For the latest from Eli Lilly, we spoke to Andrew Adams, Vice President of New Therapeutic Modalities and COVID-19 research at Eli Lilly.
Sep 18, 2020
6:43
Moderna Expects To Know If Potential COVID-19 Vaccine Works by November 
This week pharmaceutical company Moderna said the company should know if its vaccine candidate works by November. As we know, Astrazeneca and Pfizer are also working on vaccine candidates in late stage trials. For more on the latest vaccine news, we spoke to Doctor Daniel B. Fagbuyi, Obama administration biodefense expert & ER physician.
close
We use cookies and similar technologies on this site to collect identifiers, such as IP address, and cookie and device IDs as described in our Privacy Policy.